130 related articles for article (PubMed ID: 9930732)
21. The expression of retinoblastoma and Sp1 is increased by low concentrations of cyclin-dependent kinase inhibitors.
Peñuelas S; Alemany C; Noé V; Ciudad CJ
Eur J Biochem; 2003 Dec; 270(24):4809-22. PubMed ID: 14653808
[TBL] [Abstract][Full Text] [Related]
22. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases.
Abraham RT; Acquarone M; Andersen A; Asensi A; Bellé R; Berger F; Bergounioux C; Brunn G; Buquet-Fagot C; Fagot D
Biol Cell; 1995; 83(2-3):105-20. PubMed ID: 7549905
[TBL] [Abstract][Full Text] [Related]
23. Aging affects the ocular circadian pacemaker of Aplysia californica.
Sloan MA; Levenson J; Tran Q; Kerbeshian M; Block GD; Eskin A
J Biol Rhythms; 1999 Apr; 14(2):151-9. PubMed ID: 10194652
[TBL] [Abstract][Full Text] [Related]
24. CDK inhibitors suppress apoptosis induced by chemicals and by excessive expression of a cell death gene, reaper, in Drosophila cells.
Nagano M; Ui-Tei K; Suzuki H; Piao Z; Miyata Y
Apoptosis; 2000 Dec; 5(6):543-50. PubMed ID: 11303913
[TBL] [Abstract][Full Text] [Related]
25. Cyclin H activation and drug susceptibility of the Pfmrk cyclin dependent protein kinase from Plasmodium falciparum.
Waters NC; Woodard CL; Prigge ST
Mol Biochem Parasitol; 2000 Mar; 107(1):45-55. PubMed ID: 10717301
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of C2 alkynylated purines, a new family of potent inhibitors of cyclin-dependent kinases.
Legraverend M; Ludwig O; Bisagni E; Leclerc S; Meijer L
Bioorg Med Chem Lett; 1998 Apr; 8(7):793-8. PubMed ID: 9871543
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors.
Wang D; de la Fuente C; Deng L; Wang L; Zilberman I; Eadie C; Healey M; Stein D; Denny T; Harrison LE; Meijer L; Kashanchi F
J Virol; 2001 Aug; 75(16):7266-79. PubMed ID: 11461999
[TBL] [Abstract][Full Text] [Related]
28. Identification of CDK- and cyclin-like proteins in the eye of Bulla gouldiana.
Krucher NA; Roberts MH
J Neurobiol; 1994 Oct; 25(10):1200-6. PubMed ID: 7815054
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis of central and peripheral neurons can be prevented with cyclin-dependent kinase/mitogen-activated protein kinase inhibitors.
Maas JW; Horstmann S; Borasio GD; Anneser JM; Shooter EM; Kahle PJ
J Neurochem; 1998 Apr; 70(4):1401-10. PubMed ID: 9523556
[TBL] [Abstract][Full Text] [Related]
30. Circadian rhythm from the eye of Aplysia: temperature compensation of the effects of protein synthesis inhibitors.
Jacklet JW
J Exp Biol; 1980 Feb; 84():1-15. PubMed ID: 7365411
[TBL] [Abstract][Full Text] [Related]
31. FMRFamide modulates the action of phase shifting agents on the ocular circadian pacemakers of Aplysia and Bulla.
Colwell CS; Khalsa SB; Block GD
J Comp Physiol A; 1992 Feb; 170(2):211-5. PubMed ID: 1583606
[TBL] [Abstract][Full Text] [Related]
32. The radiosensitising effect of olomoucine derived synthetic cyclin-dependent kinase inhibitors.
Korinkova G; Cwiertka K; Paprskarova M; Dzubak P; Hajduch M
Neoplasma; 2010; 57(2):161-9. PubMed ID: 20099981
[TBL] [Abstract][Full Text] [Related]
33. A new, unexpected action of olomoucine, a CDK inhibitor, on normal human cells: up-regulation of CLIMP-63, a cytoskeleton-linking membrane protein.
Wesierska-Gadek J; Gueorguieva M; Kramer MP; Ranftler C; Sarg B; Lindner H
J Cell Biochem; 2007 Dec; 102(6):1405-19. PubMed ID: 17975794
[TBL] [Abstract][Full Text] [Related]
34. ATP-site directed inhibitors of cyclin-dependent kinases.
Gray N; Détivaud L; Doerig C; Meijer L
Curr Med Chem; 1999 Sep; 6(9):859-75. PubMed ID: 10495356
[TBL] [Abstract][Full Text] [Related]
35. Circadian organization in Aplysia californica.
Page TL; Hudson DJ
Fed Proc; 1979 Nov; 38(12):2580-2. PubMed ID: 499573
[TBL] [Abstract][Full Text] [Related]
36. A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein.
Ratner N; Bloom GS; Brady ST
J Neurosci; 1998 Oct; 18(19):7717-26. PubMed ID: 9742142
[TBL] [Abstract][Full Text] [Related]
37. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.
David-Pfeuty T
Oncogene; 1999 Dec; 18(52):7409-22. PubMed ID: 10602500
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of amino acids on the period of the circadian rhythm from the Aplysia eye.
Eskin A
J Neurobiol; 1982 May; 13(3):231-9. PubMed ID: 7077320
[TBL] [Abstract][Full Text] [Related]
39. Synergic effects of the cyclin-dependent kinase (CDK) inhibitor olomoucine and androgen-antagonist bicalutamide on prostatic cancer cell lines.
Knillová J; Bouchal J; Hlobilková A; Strnad M; Kolár Z
Neoplasma; 2004; 51(5):358-67. PubMed ID: 15640940
[TBL] [Abstract][Full Text] [Related]
40. Functional genomics identify Birc5/survivin as a candidate gene involved in the chronotoxicity of cyclin-dependent kinase inhibitors.
Siffroi-Fernandez S; Dulong S; Li XM; Filipski E; Gréchez-Cassiau A; Peteri-Brünback B; Meijer L; Lévi F; Teboul M; Delaunay F
Cell Cycle; 2014; 13(6):984-91. PubMed ID: 24552823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
